Gibco™ RPMI 1640 Medium

Stem cell culture media hHSCs

Experiment
Stem cell culture media hHSCs
Product
Gibco™ RPMI 1640 Medium from Fisher Scientific
Manufacturer
Fisher Scientific

Protocol tips

Upstream tips
CD34+ Cells
Protocol tips
RPMI-1640 medium (Lonza, 12-702Q) with 10% fetal bovine serum (GE Healthcare HyClone. SH30071.03), 100 ng/mL stem cell factor (SCF) (R&D Systems, #7466-SC-010/CF), thrombopoietin (TPO) (R&D Systems, #288-TP-200/CF), Fms-like tyrosine kinase 3 ligand (FL) (BioLegend, # 710802)

Publication protocol

RPMI-1640 medium (Lonza, 12-702Q) with 10% fetal bovine serum (GE Healthcare HyClone. SH30071.03), 100 ng/mL stem cell factor (SCF) (R&D Systems, #7466-SC-010/CF), thrombopoietin (TPO) (R&D Systems, #288-TP-200/CF), Fms-like tyrosine kinase 3 ligand (FL) (BioLegend, # 710802)

Full paper   Login or join for free to view the full paper.

Reviews

Gibco™ RPMI 1640 Medium from Fisher Scientific has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Stem cell culture media hHSCs using Gibco™ RPMI 1640 Medium from Fisher Scientific.

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Fisher Scientific for Gibco™ RPMI 1640 Medium below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing Stem cell culture media hHSCs using Gibco™ RPMI 1640 Medium from Fisher Scientific. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms